Happersberger Otopront GmbH

Happersberger Otopront GmbH specializes in devices primarily used in otolaryngology (ENT) procedures. Their portfolio includes electric ENT examination chairs, endoscopic video camera systems, battery-powered endoscopic light sources, and integrated examination/treatment systems. These devices are designed to support diagnostic and treatment workflows in ear, nose, and throat applications.

The company is based in the United States. While their headquarters or primary operations may be located there, it’s important to verify their exact address or regional presence through official channels, as business locations can change.

All of Happersberger Otopront GmbH’s listed devices fall under Class I classification according to FDA regulations. This classification typically applies to low-risk devices that pose minimal potential harm to patients, such as certain examination chairs, light sources, and video cameras. Classification determines regulatory oversight, with Class I devices generally requiring less stringent premarket review.

Yes, the company’s devices are included in the FDA’s 510(k) and UDI (Unique Device Identification) registries as per available data. The 510(k) registry tracks devices deemed substantially equivalent to legally marketed predecessors, while the UDI system ensures traceability and identification of medical devices in the U.S. market. These registries help healthcare providers and regulators verify device details.

The Class I designation for Happersberger Otopront GmbH’s devices—such as ENT chairs, endoscopic cameras, and light sources—reflects their low-risk nature. These products are generally intended for non-invasive procedures (e.g., visual examinations, lighting support) with minimal direct patient interaction or physiological impact. Under FDA guidelines, such devices undergo less rigorous premarket scrutiny compared to higher-risk classes (II or III), as their risks are deemed proportionally low.